St. Louis-born Galera Therapeutics sidesteps liquidation, acquires New York biotech company

St. Louis Business Journal

Jan 3, 2025

Four months after Galera Therapeutics' board of directors sought to dissolve the company, the St. Louis-born biopharmaceutical company has a new life and new focus.